Legal Representation
Attorney
Timothy X. Gibson
USPTO Deadlines
Next Deadline
77 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due Date
October 01, 2025
Grace Period Ends
April 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 1, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
Oct 1, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jul 16, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 16, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 26, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 13, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
May 30, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 30, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
May 30, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
May 30, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 30, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
May 30, 2019 | ISSR | Z | WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | Loading... |
May 30, 2019 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Apr 30, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 30, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 10, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 18, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 20, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 045
Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics
First Use Anywhere:
Sep 8, 2018
First Use in Commerce:
Sep 8, 2018
Additional Information
Pseudo Mark
FOUR C
Classification
International Classes
045